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Background: The prevalence of diabetes in Sub-Saharan Africa (SSA) is growing rapidly. Qualitative research on
experiences of type 2 diabetes in SSA is emerging, but no qualitative synthesis has been attempted. This scoping
review aims to redress this lack of synthesis and to extract policy-relevant suggestions from the literature.
Methods: Scoping review methodology was employed. Eleven online databases were searched (CINAHLplus, Cochrane
Library, EBESCOhost, GALE Group, MEDLINE, Pro-Quest, Pscyhinfo, Pubmed, SCOPUS, Web of Science, WorldCat), using
terms designed to identify qualitative studies of experiences of diabetes in SSA. Findings from records identified in the
search were analysed inductively in NVivo 10 in three stages, to produce an analytical synthesis of studies of diabetes
experiences in SSA.
Results: Searches were conducted in 2017 and identified 2743 records, which were reduced to 21 after screening. The
earliest identified record was published in 2003 and there was a clustering of records published between 2014 and 2016.
The 21 records were based in eight SSA countries: Cameroon, Ethiopia, Ghana, Senegal, South Africa, Tanzania, Uganda,
and Zimbabwe. A majority of the studies were conducted in Ghana (5) and South Africa (5), limiting the generalisability
of our findings.
The analytical synthesis produced five themes: identifying type 2 diabetes (how participants conceptualise and position
their illnesses); hybridity of diabetes care (how multiple forms of care are often blended and/or pursued concurrently);
impediments, improvisation and diabetes management (describing challenges faced, how these are responded to and
management via diet and physical activity); sources of support (who supports participants and how); and diabetes and
HIV/AIDs (the ways in which the two conditions are sometimes confused and how stigma is often experienced).
Conclusions: The experiences of people with type 2 diabetes in SSA are under-researched across the region, pointing
to a gap in knowledge. Interpreting our analytical synthesis, we suggest three priority areas for policy makers and
implementers. Firstly, uncertainties relating to access to diabetes treatment need to be reduced. Secondly, more needs
to be done to acknowledge and alleviate the economic struggles that those with diabetes face. Finally, high-quality
information and education would improve recognition and management of the condition.Background
The number of adults estimated to be living with diabetes
in sub-Saharan Africa (SSA) in 2017 was 15.5 (9.8–27.8)
million, with a regional prevalence of ~ 6%, and associated
healthcare costs of USD 3.3 billion. By 2045, this number
is expected to increase by 162.5%, with an estimated 40.7
million adults suffering from type 2 diabetes and costs
rising to USD 6 billion [1]. The increase in diabetes preva-
lence in SSA is expected to outpace all other global* Correspondence: christopher.bunn@glasgow.ac.uk
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tackling this growing diabetes burden, including limited
health and social care resources and the continued costs
of diseases such as HIV/AIDS, malaria and tuberculosis
[3]. Estimates suggest that as many as ~ 69% of SSA adults
living with diabetes are undiagnosed [1, 4], leading to a
high prevalence of diabetes-related complications and in
2017 6% of all deaths were attributed to diabetes [5].
In recent years, 89% of African countries have established
non-communicable disease (NCD) centres or departments
within their Ministries of Health [6]. Although there is a
growing wealth of epidemiological evidence to guide
national diabetes strategies, the experiences of those whole is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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Table 1 Number of records returned during searches, by
database
Database N of Records
ProQuest 817
EBESCOhost 99
GALE Group 414
MEDLINE 1382
Cochrane Library 1
Web of Science 126
WorldCat 34
Pubmed 97
Psychinfo 14
CINAHLplus 17
SCOPUS 58
Total Records 2814
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tion Studies of ‘illness experiences’ have a long history in
European sociology and social psychology, and have
focussed on understanding the subjectivities of people
living with illness, the coping strategies that they deploy,
and how they experience social structures [7]. Individual
studies of type 2 diabetes illness experiences in SSA have
drawn on this literature and considered the complex mean-
ings the condition is attributed [8], the techniques through
which people pursue self-care [9], and the negotiation of
biomedicine [10].
Such emerging literature on type 2 diabetes illness ex-
periences in the SSA region has much to contribute to
situated and policy-relevant insights, but maximising im-
pact and utility requires a synthesis of the evidence from
individual studies. The aim of our review is to redress
the lack of synthesis and to assemble all the relevant
peer-reviewed evidence in a systematic and accessible
way. Further, we aim to contribute to conversations
focussed on how to provision for the increasing numbers
of people living with type 2 diabetes in SSA, by making
policy-relevant suggestions based on findings from stud-
ies that report on the experiences of people with type 2
diabetes.
Methods
This review a scoping review framework inspired by
Arksey and O’Malley and Levac [11, 12] as follows: iden-
tifying the research question, identifying relevant studies,
selecting studies, charting the data, summarising the
results. We describe the review process using these five
steps, which were carried out by MZ and overseen by
CB through regular meetings and discussion.
Identification of the research question
Our research question was developed through discussion
to focus the review on: a target population (people living
in sub-Saharan African); a concept (illness experiences);
and health condition (type 2 diabetes) [12]. The final
question which guided the review was: In existing quali-
tative studies, what is known about the illness experi-
ences of people with type 2 diabetes in Sub-Saharan
Africa?
Identification of relevant studies
To identify studies, keyword sets were utilized in
searches of academic databases. These keyword sets
were established through an iterative process (test and
refine). Concepts of illness experience identified in the
literature were employed in the first keyword set (e.g.
‘biographical disruption’ [13]; ‘narrative reconstruction’
[14]; ‘illness work’ [15]). However, the concept of illness
experience proved hard to operationalise, and our
searches did not return the records we were expecting,including records identified as relevant in advance of the
search. Accordingly, we opted for a broad search strategy
and the final keyword set was: (Africa) AND (diabetes)
AND (qualitative). Eleven databases were searched (see
Table 1). Searches were carried out in February and March
2017, no limitation was put on the publication date of the
records, but we restricted the search to peer-reviewed
studies written in English. The references of included
papers were checked for papers of potential interest.
While Arksey and O’Malley suggest that grey literature
should be included, pragmatic, time-based restrictions on
the work led us to the decision to exclude this literature.
Finally, we consulted with two researchers based in SSA
who are engaged in diabetes-related work.
Study selection
We used the following inclusion criteria for the title and
abstract screening: studies including primary qualitative
empirical data on patient experiences of type 2 diabetes;
studies based in a SSA country (using the World Bank’s
definition of the SSA region [16]). Reviews were
excluded, but no review of diabetes experiences was
identified. If abstracts indicated a focus on the experi-
ences of others, such as medical professionals or carers,
they were also excluded. After the titles had been
screened, the same inclusion and exclusion criteria were
applied to the abstracts. While the title screen only looked
for potential evidence of qualitative data, abstracts were
reviewed for specific reference to illness experiences.
Following abstract review, full texts were accessed for final
screening and data extraction.
Charting the data and summarizing the results
Our data charting and exploration was guided by
Thomas and Harden’s three-stage approach to qualita-
tive data synthesise [17]. The results sections from all
Zimmermann et al. Global Health Research and Policy  (2018) 3:25 Page 3 of 13records were imported into NVivo 10, analysed induct-
ively and coded line-by-line by [MZ], using codes dis-
cussed and agreed with [CB]. We then grouped related
codes to create new ‘top line’ codes to describe the
groupings, and used these ‘top line’ codes to create ana-
lytical themes. We then tabulated the records to make
the distributions of themes across the review clear.
Results
The initial search terms yielded 2814 total records (see
Table 1). After 71 duplicates were removed, a further
2661 records were screened out during a review of titles.
The abstracts screen excluded a further 51 papers,
leaving 31 papers to read in full. When screening and
reading were completed, 21 papers were included in the
final review (see Fig. 1). The 21 articles represented studies
in 8 Sub-Saharan countries: Ghana (5), South Africa (5),
Tanzania (3), Cameroon (2), Ethiopia (2), Uganda (2),
Senegal (1), and Zimbabwe (1) (see Fig. 2 for a map-based
visualisation). Of the studies identified, 10/21 were
conducted in Ghana and South Africa, and only 8 of 48
SSA countries were represented. Figure 3 graphs theFig. 1 Scoping review flow diagrampublication dates of the 21 studies and demonstrates the
emerging nature of the literature. Median number of par-
ticipants across the 21 studies was 25, with a range of 9–
82 and a total of 594. Table 2 details study methods and
participants, as well as a visual representation of themes
attributed to each of the 21 papers.
Our analytic synthesis produced five themes. Identify-
ing type 2 diabetes collects together how participants/in-
formants recognised and interpreted their condition.
Hybridity of diabetes care reports findings relating to
how participants blend approaches (notably biomedical
and traditional) to caring for their condition. Impediments,
improvisation and diabetes management describes find-
ings concerning the challenges that informants reported,
how they were overcome, and the steps taken to
self-manage through diet and physical activity. Sources of
Support summarises findings relating to the social,
emotional and practical supports that participants
reported receiving. Finally, Diabetes and HIV/AIDS looks
at how informants described the relationships between
the two conditions, particularly how the former is often
mistaken for the latter.
Fig. 2 Map of studies of diabetes experiences in SSA identified in this review (countries in black stripes are not part of the SSA region)
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Findings relating to how Participants recognised and
interpreted their type 2 diabetes were reported in most
papers included in the review [8–10, 18–34]. A recurring
observation was that the symptoms of diabetes were
often not recognised by those experiencing them, and
healthcare professionals tended to be the first to respond
to signs of the disease [8, 21, 26, 27, 30, 33]. For ex-
ample, an informant in Hjelm and Munfunda’s study ofFig. 3 Distribution of studies included in the review by yearhealth beliefs amongst Zimbabweans with diabetes
described:
“...experiencing a feeling of tiredness, loss of weight,
dryness of the mouth and passing lots of urine...I got
confused because I failed to understand what was
happening....feeling of dying...went to seek advice from
a sister-in-law (a nurse)...tested my urine...then taken
to a private doctor.” [8]
Table 2 Studies included in the scoping review
Authors
(Year)
Country Participants Methods Themes Covered in the Study
Identifying
type 2
diabetes
Hybridity of
diabetes
care
Impediments,
improvisation
and diabetes
management
Sources
of
Support
Diabetes
and HIV/
AIDS
Adeniyi
et al. (2015) [18]
South
Africa
17 people with diabetes
with HBA1c≥ 9%
registered in a single
clinic
Interviews x x x
Aikins (2003) [19] Ghana 28 people with
diabetes recruited
using snowballing
and opportunistic
methods
Interviews x x x x x
Aikins (2005) [20] Ghana 26 urban people and
41 rural people with
diabetes recruited
through 2 clinics,
1 self-help group and
snowball sampling
Interviews, Focus
group discussion,
Ethnography
x x x x
Awah and Philimore
(2008) [21]
Cameroon 82 people with diabetes
registered at 1 of 4
clinics included
in the study
Interview,
Ethnography
x x x x
Awah, Unwin and
Phillimore (2008) [10]
Cameroon 20 people with diabetes
and their families registered
at 1 of 4 clinics
Participant
Observation,
Fieldwork,
interviews, Focus
group discussion
x x x x
BeLue et al.
(2012) [22]
Senegal 54 people with diabetes
registered at a single clinic
Interviews x x x x x
Booysen and
Schlemmer
(2015) [23]
South
Africa
29 people with diabetes patients
with Hgt > 12 mmol/l Recruited
through a single community
health centre
Interviews, Focus
group discussion
x x x
Broder et al.
(2014) [24]
Ghana 59 people with diabetes
recruited from Ghana’s National
Diabetes Research and
Management Centre
Focus group
discussion
x x x
Doherty et al.
(2014) [25]
Ghana 40 people with diabetes
registered at a single clinic
Focus groups,
semi-structured
interviews
x x
Habte et al.
(2016) [26]
Ethiopia 39 people with diabetes
registered at 1 of 3 clinics
Semi-structured
interviews
x x x x
Hjelm and
Nambozi
(2008) [27]
Uganda 25 people with diabetes
registered at a single clinic
Semi-structured
interviews
x x x
Hjelm and
Mufunda
(2010) [8]
Zimbabwe 21 people with diabetes
registered at a single clinic
Semi-structured
interviews
x x x x
Kagee, Le Roux
and Dick,
(2007) [28]
South
Africa
9 people with diabetes registered
at 1 of 4 clinics
Semi-structured
interviews
x x x
Mendenhall
and Norris
(2015) [29]
South
Africa
27 people with diabetes
recruited from an existing
cohort study
Semi-structured
interviews
x x x x
Metta et al.
(2015a) [30]
Tanzania 35 people with diabetes
recruited from a single clinic
Focus groups,
semi-structured
interviews
x x x x
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Table 2 Studies included in the scoping review (Continued)
Authors
(Year)
Country Participants Methods Themes Covered in the Study
Identifying
type 2
diabetes
Hybridity of
diabetes
care
Impediments,
improvisation
and diabetes
management
Sources
of
Support
Diabetes
and HIV/
AIDS
Metta et al.
(2015b) [31]
Tanzania 19 people with diabetes
recruited from the community
and the local diabetes clinic
Semi-structured
interviews
x x x
Murphy
et al.
(2010) [9]
South
Africa
13 people with diabetes
recruited from 1 of 3
community health centres
Semi-structured
interviews
x x x x
Mwangome
et al. (2016)
[32]
Tanzania 9 people with diabetes
recruited from 1
faith-based organisation
facility
Semi-structured
interviews
x x x x
Nielsen et al.
(2016) [33]
Uganda 10 people with diabetes
identified through a
household survey
Survey,
Interviews,
Observation
x x x
O’Brien et al.
(2015) [35]
South
Africa
19 people with diabetes
recruited from private
and public healthcare
providers
Interviews x x x
Tewahido and
Berhane (2017) [34]
Ethiopia 13 people with diabetes
recruited from 1 of 2 clinics
Interviews x x x
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nurse was able to recognise and respond to her
brother-in-law’s symptom, after interpreting them as a
sign of potential diabetes.
Once diagnosed with type 2 diabetes, many reacted
with shock, and some initially perceived the condition as
posing an immediate threat to their lives:
“When told that I had this illness I thought I would
die the very next day. I didn’t think that I would get
to live for all these years because I had no knowledge
about the disease.” [26]
However, as this Ethiopian man implicitly narrates,
after gaining ‘knowledge’ he understood that the condi-
tion need not kill him.
Most studies found that the majority of people
with diabetes understood the links between high
sugar diets, inactivity, and obesity as contributors to
diabetes. However, there was also evidence that some
people with diabetes questioned the links between
lifestyle and diabetes, particularly when neither their
bodies nor lifestyles reflected dominant narratives
which positions type 2 diabetes as a disease of affluence
[8, 18–20, 22, 25]:
“There is no relationship between obesity and control
of diabetes at all, look at me how tiny and poor I am
and it is difficult to control my diabetes.” [18]Echoing this South African woman’s association of dia-
betes and wealth, one study reported that in Ghana, dia-
betes is referred to as ‘esikafoo yare’ (‘disease of the
wealthy’) [19]. A participant in Senegal develops this
narrative further, describing key markers of urbanisation
and modernisation as underlying causes of lifestyle tran-
sitions which exacerbate diabetes risk:
“the population is so inactive of course diabetes
will be very present here. A while ago when we
used to be farmers and the population was active
we didn’t have diabetes, hypertension or thyroid.
With technology cars, computers etc., we became
sedentary and we started seeing all of these
diseases.” [22]
The arrival of processed food, new technology, and
consequent shifts in lifestyle were all offered as drivers
of increasing diabetes prevalence.
The chronic nature of diabetes was also a source of
contention for study participants [10, 19, 20, 24, 26, 30].
The majority of studies found that people with diabetes
understood that diabetes was a chronic condition for
which there was no cure, as this Tanzanian woman ex-
emplifies [10, 18, 21, 24, 26, 27, 31, 32]:
“…Diabetes is not a curable disease. Rather, the
medicines we are using are just for relief; that is what
we were told at the clinic one day.” [31]
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diabetes cannot be cured, it can be managed. However, a
significant number of studies found that some partici-
pants were hopeful that there was a cure. In the studies
by Aikins (Ghana) [19], Awah, Unwin and Phillimore
(Cameroon) [10], Habte et al. (Ethiopia) [26], and Hjelm
and Nambozi (Uganda) [27], some informants rejected the
chronic nature of diabetes and instead spoke of a cure for
the disease. Awah, Unwin and Phillimore attribute the
rejection of diabetes as a chronic condition in part to the
belief that some held that all disease should have a cure,
suggesting that this motivates searches for understanding
and cure in non-biomedical domains [10].
Studies also found that some informants, such as this
person from Tanzania, initially attributed their diabetes
to witchcraft [8, 10, 19–21, 27, 30]:
“When I contracted diabetes I was very fat. I had a big
belly, but it disappeared after only three days. I mean
everyone who saw me was surprised, saying, ‘It has
only [been] three days!’ That is why I went to the
traditional healer. I was afraid because I had changed
a lot; it was a big change for just three days. I thought
I was bewitched…” [30]
However, witchcraft and appeals to the supernatural
were not simple replacements for biomedical explana-
tions. Rather, biomedicine and traditional medicine are
not mutually exclusive. [8, 10, 19, 21]:
“I will just finish these[…] drugs because I bought
them. But tomorrow, I will go for more protection
and tell the native doctor that he is a man. He
knows his job. I must not joke at my workplace
because there is a lot of witchcraft and jealousy
there; they have put this diabetes into my body.
My family told me in the village that I should
be careful… My man will cure me and that enemy
will be ashamed” [21]
As this Cameroonian exemplifies, the two discourses
can become entangled.
Hybridity of diabetes care
Thirteen studies focused on how people with dia-
betes employed both biomedical and non-biomedical
services in the management of their type 2 diabetes
[8–10, 19–22, 24, 26, 27, 29, 31, 35]. Employing
non-biomedical services was frequently narrated as
part of a search for a cure, as described by this
Ghanaian [10, 19–21, 30]:
“I want to be healed so I will follow up whenever I
hear of somebody who can help.” [19]Some searches for cures were directly linked to a per-
ceived failure of biomedical practitioners to provide a cure.
“I was never at ease when the doctor told me that I
had diabetes. I tried to be cured in the hospital and
my diabetes could not finish. The doctor kept telling
me that I was not complying with treatment. A friend
of mine also, sick with diabetes, told me that some
unperformed ritual might be holding back the
treatment. She advised me to consult a traditional
healer. The healer advised me on the ritual to perform
to my ancestors. After the ritual, I felt well and my
blood sugar returned to normal six months afterwards.
I believe that the doctor did not know this other cause
of my diabetes and how I could be cured.” [10]
Informants such as this Cameroonian spoke of frustra-
tion at the lack of a cure and continued suffering as reasons
for engaging non-biomedical healers. When informants
assessed their treatment regimens to be of low efficacy,
they looked to other forms of treatment.
The financial pressures that biomedical treatments
often place on households was another reason offered
for consulting non-biomedical services. Non-biomedical
services cost less than biomedical services, providing a
cheaper alternative to those struggling to afford to pay
for biomedical services, as represented by this Senegal-
ese narrative [10, 19–22]:
“The main problem we have with diabetes is the diet
and the medications are extremely expensive. The
cheapest drugs are between 60 to 100 dollars a
month. For a third world country like Senegal, it is
almost impossible for most of us to be able to afford
it. Most of the diabetic patients are living in misery or
dying. The situation is that extreme. A money issue is
the main reason why most of us try traditional plants
because it is more economical” [22]
Even though non-biomedical services are routinely uti-
lized, biomedicine was often reported to be both pre-
ferred and the first source of diagnosis [9, 19, 20, 22, 24,
26, 35]. An stark example of this comes from South
Africa:
“I just follow instructions as the doctor said to me. I
decided ok, the doctor told me this and this, which is
why I have to follow it, because they know what I don’t
know. They saw it in my body…so I just carry on..” [9]
Moreover, when symptoms worsened, non-biomedical
explanations and treatments for diabetes tended to be
downplayed by participants in favour of biomedical
alternatives.
Zimmermann et al. Global Health Research and Policy  (2018) 3:25 Page 8 of 13A number of studies described a situation where both
biomedical and non-biomedical services were used inter-
changeably [10, 19, 21, 22, 26, 30]. This mixing of system
could be due to the lack of access for biomedical treat-
ments [31], or simply a prevailing notion that mixing
traditional and biomedical systems resulted in the better
outcomes [10, 19, 20, 24, 26].
‘Let health care providers do their part, the traditional
healers will complete the treatment’ [10]
As described by this Cameroonian, hybridising
multiple systems is not uncommon. Participants
often take multiple forms of medication, mix advice
from a variety of healers, and deploy variegated con-
ceptual frameworks in their accounts of how they
care for themselves.
Alongside traditional healers and biomedical health-
care professionals, religious beliefs also contribute to
treatment discourse. Many informants attributed any
potential success in treating their diabetes to God’s
will. Those who went to faith-based healers or en-
gaged in prayer as a form treatment considered God
to be the ultimate healer [19, 20, 24, 26, 31, 33]. In
Cameroon, participants described the belief that God
could impact all aspects of treatment: from blessing
food and medication, to guiding a person to a good
doctor.
“It is only God who can intervene. It is only God who
can let you meet a doctor who can cure you of the
disease.”
“If God doesn’t bless the drugs you take it might not
be effective even though it is efficacious.” [20]
Christian healing manifested itself in many practices
including special diabetes prayers, taking communion,
being anointed with holy water, and visiting dedicated
faith healers. In combination with biomedical services,
the inclusion of religion was seen as an effective method
to find a cure [8, 19, 20, 24, 26, 27, 29].Impediments, improvisation and diabetes management
All 21 studies in the review reported narratives relating
to the impediments people with diabetes face when
managing their diabetes. The high costs of medication
was a major concern for people held by people with dia-
betes studie [8, 9, 19–22, 27, 28, 31, 32, 34, 35]. As
highlighted by BeLue et al., the cheapest medication in
Senegal is unaffordable for most [22]. Also patients are
often advised to take multiple medications to treatexisting or prevent future comorbidities, as narrated in
Ethiopia:
“. . .The drugs are not affordable. . .besides diabetes
doesn’t come alone. There’s the cholesterol and
hypertension that come along. I struggle to cover all
that with my government salary.” [34]
Another cost identified in three studies was the cost of
diabetes monitoring equipment, with participants in
Uganda reporting that managing treatment is made
more difficult by an inability to afford monitoring equip-
ment to test their blood sugar levels [8, 18, 27]. “.. . the
machine for testing is very expensive. Can’t afford about
60 000 shillings.” [27]
One study reported that informants would sometimes
buy their medication directly from local pharmacies
without attending clinics to obtain an appropriate pre-
scription, to avoid healthcare and transportation costs
[32]. Other methods of managing diabetes under finan-
cial constraints were focused on prolonging medica-
tion supplies. In Tanzania, this included reducing
dosages or sharing medication with other people with
diabetes [31, 32].
“…Medicines are very important for treating this
disease…That is why you find people using a half of the
dose and saving the rest for the days ahead, because
you do not know how it is going to be tomorrow…
[Have you experienced that situation?] Yes…sometimes
instead of injecting myself twice in a day I inject myself
only once… At least when I do this the medicine for a
month can last me two months.” [31]
Improvisations in treatment practices were not just re-
lated to medication, but also occurred as a response to a
lack of blood glucose testing equipment. One participant
described testing sugar levels by tasting urine for sweet-
ness or looking to see if ants are attracted to it [32].
Accessing clinics, hospitals and other biomedical
facilities was a significant impediment for some. In
four studies, informants reported that biomedical fa-
cilities were too far away to reach easily, often due
to the cost of transport. This was especially true for
those who lived in remote villages in rural or
semi-rural areas [18, 28, 30–32].
“I need to have enough money for a return transport,
accommodation, and food before I can think about
going to the clinic—and that doesn’t include the
money for laboratory tests and medicines… my
financial resources are low….I just leave it to God—if
I have money I go to get the medicines, and if I don’t,
I stay home and go without….” [31]
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pants such as this Tanzanian woman required money for
accommodation and food in order to make the journey
to her nearest diabetes clinic. During rainy seasons,
clinics also become unreachable for some:
“….During the rains it is very difficult to come to the
clinic because our roads are impassable, and cars are
unable to reach the village….. This is why even I
could not come to the clinic last month…” [31]
Even when clinics were accessible, the treatment and
care described in the literature was often inadequate [18,
28, 29, 31, 32]. For example, medication was not always
available at local health clinics, such as this one in
Tanzania:
“…For instance, last year diabetes medications
disappeared for almost three weeks … I could not find
them anywhere in Ifakara … and during that time I
didn’t have a single medicine from the hospital….
That it is when you find us in these other places (local
healers/herbalists).” [31]
Alongside disruptions to the supply of medicines, in-
formants also described long delays at health clinics.
These delays often entailed losing wages or labour time,
and some reported fainting as a consequence of waiting
for fasting blood glucose tests [8, 31, 32].
Informants reported how diabetes also impacted their in-
comes. Six studies recounted the impacts that diabetes had
on informants’ ability to work [8, 19, 22, 23, 26, 28, 29].
Diabetes often resulted in early retirement, as a result of
diabetes-related impairments.
Complications such as decreased mobility, or poor
eyesight were contributing reason for people having to
retire early [26]. One Senegalese person simply stated:
“I am blind and cannot support my family.” [22]
Earnings were also lost due to time spent seeking
treatment. Kagee, Le Roux and Dick found that par-
ticipant in South Africa reported losing their wages
when they had to go to and travel to biomedical
facilities:
“You miss a day’s wages. So you see money plays a
role whether or not I go to the clinic. What do you
think?” [28]
In some instances, informants described living with
diabetes as stressful [8, 9, 21–23, 26, 27, 29, 34],
which was often related to financial concerns, as in
this Ghanaian case:“It is frightening when you don’t have money to buy
drugs, but if you have money then your mind is at
ease.” [19]
As well as financial stresses, participants were con-
cerned about managing their conditions. Specifically, the
inability to monitor glucose levels and struggles to keep
diabetes under control were both described as sources of
stress by South African participants [9, 29]. Finally, fam-
ily conflicts about food were also sources of stress when
the dietary changes to treat diabetes affected household
meals [22, 23, 29].
Exercise as a way to manage diabetes was discussed in
eleven studies [8, 9, 18, 22–24, 27, 29, 33–35]. There
were mixed result in the uptake of exercise. Some infor-
mants discussed how they incorporated exercise in daily
activities: “I care for the baby so I am always moving
around the house” [29]. Reasons for not taking up exercise
included pain when exercising, and the view that the en-
vironment was not suited to exercise [24, 25, 34, 35].
informants from South Africa said that they did not feel
safe enough in the neighbourhoods to exercise outside
[23], while participants in Ethiopia lamented the lack of
affordable facilities [34].
Another impediment to self-care reported in the lit-
erature related to the foods that participantshad ac-
cess to. Eleven studies focused on how informants
found sustaining an appropriate diet a pressure on fi-
nances [8, 9, 18–20, 22, 25, 28, 29, 32]. Participants
in Senegal described the high cost of vegetables and
lean meats [22]. Sourcing sufficient vegetables was a
concern for the Informants in Ghana [20]. Others
noted that when a type 2 diabetes-appropriate diet
was consumed by the entire household, expenditure
on food increased [23, 25, 28]. This led one South
African to conclude: “No, you will lose your house
and your car to afford those foods”. [23]
Sources of support
Twelve studies reported on the sources of support
that people with diabetes were able to draw on [8, 9,
18, 20, 22, 23, 28–30, 32–35]. For many, family and
friends were the most important sources of support.
Support described came in multiple forms, from pro-
viding financial aid to making sure that treatment
regimens are followed, as was evidenced by one par-
ticipant from Senegal:
“I get a lot of support from my family and from my
friends thank God. I cannot complain and I am very
grateful. My son who was born in 1974 is a grown
man and he helps me a lot financially. The rest of my
family supports me mentally. My wife and my
daughter-in-law cook my food.” [22]
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included reminders to take medicines [22, 28, 32, 33], as
described by this Ugandan:
“When I’m in bed and my granddaughter has
prepared food, she wakes me up and says, ‘Food is
ready, take your medicine.” [33]
Metta et al. found that when initially confronted with
diabetes symptoms, informants turned to friends (as well
as family) for assistance [30]. Like family, friends also
provided financial support, by lending cash [8, 31]. A
South African informant also described forming sup-
portive friendships with other people in their community
who live with diabetes:
“People have been supportive [of my diabetes]. My
neighbour now also has it and we are always talking
about it together and I enjoy being around her. We
usually share a laugh about it sometimes”. [29]
While many participants described living in supportive
environments, with helpful family and friends, some nar-
rated feeling unsupported in caring for their diabetes
[22, 23, 29, 35]. Three studies found that tensions relat-
ing to food often arose in families, including resistance
to making changes to household meals to accommodate
the diabetes-related needs of one person (South Africa
and Senegal) [22, 23, 29]. One Senegalese participant
even suggested that her daughter-in-law was acting out
of spite towards her:
“...My daughter-in-law knows that I am diabetic but
she cooks rice a lot because she doesn’t want me to
do well.” [22]
Similarly, tensions over diet could also occur between
friends. One study from Ethiopia found that during so-
cial events, refusal to eat from a common dish was con-
sidered inappropriate, forcing people with diabetes to
choose between adhering to their diet or maintaining
good relations [34].
Some participants felt that they did not get the neces-
sary levels of support from their health care providers [8,
9, 18, 21, 23, 33, 35]. Booysen and Schlemmer, describe
how some participants felt that nurses were too strict
with them and humiliated them in front of others [23].
An unsympathetic health care system was also men-
tioned by participants in Kagee, Le Roux and Dick’s
study [28]. While informants in Murphy et al.’s study
reported that when doctors voiced disapproval, it made
them nervous to ask questions [9]. An additional way in
which participants described feeling unsupported by health-
care providers related to the quality of information abouttheir diabetes that was made available [9, 18, 23, 33]. For
example, participants in Uganda described how often doc-
tors did not explain what their blood glucose test results
were, or failed to provide accessible records:
“At the hospital they don’t tell the numbers—just
write them. If they [the nurses] write large I can read
them myself, but if they write too small, I have to ask
my brother’s granddaughter or the neighbor’s child to
read them because I do not see well.” [33]
The lack of education on managing diabetes was men-
tioned in eight studies [9, 18, 23, 24, 27, 29, 32, 33, 35].
Informants reported that they need more information
on medication and diets.
Diabetes and HIV/AIDS
The HIV/AIDS epidemic in SSA has had an impact on
the ways in which diabetes has been understood and its
symptoms interpreted. Eight studies explored aspects of
this relationship [10, 19–22, 26, 30, 32]. As we described
earlier, most informants in literature we identified were
unaware that their symptoms were indicative of diabetes,
and instead attributed to them to other causes. Four
studies found that initial interpretations of their symp-
toms lead many to assume that they had HIV/AIDS or
other diseases such as malaria [8, 26, 27, 30]. This con-
fusion of diagnosis was due to the lack of awareness of
diabetes, the weight loss, inability to explain the cause of
their symptoms, and the high rates of communicable
diseases in their communities.
“Initially, I used to urinate a lot; also drank water a
lot… When my condition further worsened and I
continued to lose weight and couldn’t even go to the
toilet by myself, I wondered if I might have contracted
AIDS.” [26]
The assumption, in this Ethiopian context, that
diabetes symptoms such as weight loss were attributable
to HIV/Aids was not only held by those experiencing
such symptoms them [10, 19–21, 26, 31]. Metta et al.
describe how one participant described how other
people thought that he had HIV/Aids [30], as did Awah,
Unwin and Phillimore [10]. In such instances, partici-
pants were subject to similar forms of stigma as those
living with HIV/Aids, as described by this Cameroonian:
“My weight was 90 kg when I was less than 35 years
old. I have lost more than 10 kg as part of my
treatment. People now perceive me as someone that is
suffering from AIDS. This is affecting my personality.
I have to gain some weight to remove that stigma and
show them I am well...” [10]
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explain their diagnosis, as family and community mem-
bers thought that the person with diabetes was actually
HIV positive.
“Why is your health so unstable… have you been
tested (for HIV)?’ Even when you say I have been
tested and I am just fine, you still hear: ‘You had
better get another test at another place because
sometimes they can miss it, if the second test shows
you are ok, then you can be completely sure’” [30]
Stigma, as narrated by this Tanzanian person, also im-
pacted the ways in which people with diabetes engaged
with their treatment. From the four studies, paricipants
detailed how they adjusted treatment regimens to avoid
the stigma of the presumption of having HIV/AIDS.
This was done by avoiding weight loss, or in the case of
one Ghanian woman, ending treatment [19, 21].
Discussion
This review found 21 studies relating to type 2 diabetes ill-
ness experiences in 8 of 48 SSA countries, published be-
tween 2003 and 2017. Interviews (mostly semi-structured)
were the most common form of data collection (20/21)
and focus groups were also popular (6/21). Studies in
Ghana and South Africa accounted for nearly half of the
records included in the review (10/21). At this very basic
level of analysis, and as encouraged by scoping method-
ology [11], our work highlights a significant gap in know-
ledge relating to the illness experiences of people with
type 2 diabetes in SSA. In plain terms: our searches
returned no studies from 40/48 SSA countries.
With these geographical and cultural limitations in
mind, we were nonetheless able to identify five areas of
convergence in the literature from the 8 countries repre-
sented in the literature. Most studies (20/21) offered
data on how people came to identify their diabetes, how
they reacted to being diagnosed and how they located
the condition using multiple pre-existing cultural frame-
works. A majority of studies (13/21) described how bio-
medical, ethnomedical and faith treatments are often
hybridised by people with diabetes in SSA, who locate
their condition in multiple socio-cultural frameworks,
are sometimes in pursuit of a cure, and often face finan-
cial and/or access issues that shape the treatment pro-
viders they can consult. All 21 studies included in the
review reported on the various impediments people
living in SSA face when pursuing care. These in-
cluded issues of cost, access, interruptions to drug
supplies and stress. Sources of support were described
in 13/21 studies, with family and friends featuring
heavily and some comment being made on levels of
support received from medical professionals. Finally,intersection between HIV/AIDS and diabetes were de-
scribed in 8/21 articles. Participants in these studies re-
ported initially interpreting diabetes symptoms, such as
weight loss, as signs of HIV/AIDS, and that this inter-
pretation was often shared by others in their community,
leading to stigma.
Taken together, the 21 studies paint living with type 2
diabetes in SSA as a complex and multifaceted experience,
often characterised by considerable challenge. Our inter-
pretation of the five themes synthesis that we have pre-
sented suggests that three major challenges can be
identified in the literature. Uncertainty is arguably one of
the leading challenges: supplies of medicine are inter-
rupted [31]; incomes fluctuate and affect access to treat-
ment [22]; visits to clinics can be disrupted by weather
and cost [31]; and, above all, the condition itself can be
difficult to anticipate and control [9]. Similarly, economic
resources shape patient experiences: treatments (including
travelling to obtain them) are unaffordable for many, espe-
cially when multiple drugs are prescribed [34]; diabetes
limits earning potential, undermining resources available
to fund care [22]; and resource constraints in health sys-
tems arguably limit the support that healthcare profes-
sional can provide patients with [9]. Finally, accessing
quality information and education about diabetes is not
easy in SSA: healthcare services are stretched, often leav-
ing little time for education [33]; information is tailored to
affluent patients, for example, through the assumption
that access to medications is stable; and lack of informa-
tion in communities contributes to the stigmatisation of
diabetes, and to inabilities to identify the condition when
confronted with symptoms [30].
While stemming from work in 8/48 countries, and
with a limit on generalisability (10/21 were from 2 coun-
tries), these three challenges (uncertainty, economic re-
source, and quality information/education) are a useful
starting point for focussed, collective action to improve
the lives of those living with type 2 diabetes in SSA and
could be addressed by a range of stakeholders. Policy
makers could consider how they might reduce the un-
certainties experienced by people with type 2 diabetes;
how they might enhance the economic affordances of-
fered to people with the condition; and how they may
provide high-quality prevention and self-management
education at both a population and localised (commu-
nity) level. Health care professionals could develop expli-
cit protocols for managing uncertainty, economic
instability and access to quality information. Pharma-
ceutical companies could make greater efforts to ensure
that cheap, first-line treatments such as metformin, are
readily available. Finally, a range of civil society organisa-
tions, including national diabetes foundations, faith-based
congregations/organisations, sports clubs, educational es-
tablishments and other socio-political collectives offer
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tion and management strategies/programmes could be
pursued.
A primary limitation of this scoping review is that it
only admitted peer-reviewed articles from the databases
that we searched. ‘Grey literature’ studies were omitted
by design, which means that this review does not con-
tain findings from non-peer reviewed studies, such as
those produced by non-governmental organisations.
This is a departure from the Arksey and O’Malley
framework and resulted from time and resource con-
strains. However, the broad terms of our search offer the
study a strength. Rather than narrowing our concern to
specific aspects of the experiences of people with type 2
diabetes, our scoping review had no pre-conceived vision
of what these experiences might be. An equally import-
ant limitation of the review is that it covers only 8/48
SSA territories, limiting generalisability. That said, this
work has clearly identified a gap in knowledge that
needs redressing if SSA countries are to improve the ill-
ness experiences of those with type 2 diabetes. Limiting
our searches to studies in English is a further limitation,
but one that was unavoidable due to the language skills
present in the team. Finally, our consultations could
have been broader, which may have resulted in add-
itional literature being identified.
Conclusions
Research focussed on exploring the illness experiences
of people living with type 2 diabetes is yet to cover the
broad territory that is SSA. Based on an analytical syn-
thesis of the evidence presented in 21 studies from 8/48
SSA countries, this scoping review has identified uncer-
tainties, economic resources and quality information and
education as key concerns for people living with diabetes
in SSA. Governments, civil society organisations,
culturally-sensitised public health practitioners and dia-
betes specialists could work collaboratively to produce
interdisciplinary and pragmatic approaches to manage-
ment and care for those living with type 2 diabetes, as
well as prevention for those who are at risk of develop-
ing the condition.
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